Rifaximin Oral Suspension 100 MG – RIFEXIL Suspension – 60ML

RIFEXIL Suspension – 60ML – Rifaximin Oral Suspension 100 mg is a gut-selective, non-systemic antibiotic formulated for the effective management of intestinal infections, acting locally in the gastrointestinal tract with minimal systemic absorption. Rifaximin works by irreversibly binding to the β-subunit of bacterial DNA-dependent RNA polymerase, thereby inhibiting RNA synthesis and preventing bacterial growth, which helps reduce pathogenic intestinal flora and control associated symptoms.

Marketed by: Wonne International Pvt. Ltd.

• Targeted Gut Action: Acts locally in the intestine with negligible systemic absorption.

• Broad-Spectrum Antibacterial Activity: Effective against a wide range of Gram-positive and Gram-negative enteric pathogens.

• Low Risk of Systemic Side Effects: Minimal absorption reduces the chances of systemic adverse effects.

• Supports Faster Symptom Relief: Helps control diarrhoea and associated gastrointestinal symptoms.

• Pediatric-Friendly Formulation: Palatable orange flavour ensures better acceptance and compliance.

Can be Prescribed by:

• Pediatricians

• Gastroenterologists

• General Physicians
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion.